The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
Neonc Technologies, Inc.
AstraZeneca
Radiopharm Theranostics, Ltd
MacroGenics
MacroGenics
SystImmune Inc.
SN BioScience
Boundless Bio, Inc.
Radiopharm Theranostics, Ltd
ImmunityBio, Inc.